Contact Form Contact Form

Protective Orders in Drug Product Liability Litigation

Protective Orders in Drug Product Liability Litigation

After a drug product liability lawsuit is filed, both the plaintiff and the defendant engage in a process called discovery. The purpose of discovery is to allow a party to learn more about the important facts of the case before trial and the other party’s evidence. The scope of discovery is very broad. It covers any information relevant to the case or that may lead to relevant evidence. Privileged information and the work product of the opposing party’s lawyer (the lawyer’s written observations, theories, opinions, and research) do not have to be disclosed. Privileged information includes oral and written communications between an attorney and his/her client.

 

Protective Orders

 

Protective orders are court orders that limit discovery. Protective orders are common in litigation involving drugs or medical devices. Protective orders cover information, such as the drug or device company’s trade secrets and other confidential information; information about the identity of patients (other than the plaintiff) and their doctors; the unpublished data of independent researchers; litigation databases; and, as noted above, the attorney’s work product and privileged communications.

 

 

Trade Secrets and Other Confidential Information

 

Drug companies are generally granted protective orders for their trade secrets and other confidential research. A trade secret is information used in a company’s business that gives it a competitive advantage. Trade secrets include formulas, patterns, manufacturing processes and customer lists. The courts, however will not grant protective orders restricting disclosure of all documents. They require the drug company to specify documents or groups of documents they seek to protect.

 

 

Discovery of Patient Information

 

The drug company might be reluctant to disclose drug or device experience reports received by it unless it can protect the names of patients who filed such reports. Also federal agencies, such as the Food and Drug Administration, collect patient information and medical records to conduct epidemiological studies (studies that show any association between the use of a drug or device and an injury or illness). In this situation, the federal agency might refuse to release the documents unless personal identifying information is removed from them.

 

 

Unpublished Research Data

 

Medical researchers generally do not release preliminary data collected in clinical studies on drugs or medical devices. After such data is collected, researchers analyze the data extensively before reaching any conclusions. Litigants sometimes seek access to raw data or preliminary results relating to scientific research. Access to such information is generally denied through a protective order because the data is incomplete and may be misleading.

 

 

Litigation Databases

 

The plaintiff and the defendant in drug product liability cases often set up litigation databases  used in preparing the case. These databases include documents, transcripts of deposition and trial testimony, discovery requests, relevant medical and scientific literature, and information about expert witnesses and doctors. The plaintiff might seek disclosure of the defendant’s database or vice versa. Such databases are generally considered attorney work product, and the opposing party cannot discover the information.

Copyright 2012 LexisNexis, a division of Reed Elsevier Inc.

Recent Blog Posts

Update on Wrongful Death Claim Against Apple for Not Implementing Lock-Out Technology

Update on Wrongful Death Claim Against Apple for Not Implementing Lock-Out Technology This week a judge in a Santa Clara Superior Court sided with Apple. in a tentative ruling, Riggs vs. Apple, Inc. History of the Wrongful Death Claim Multiple plaintiffs who had lost children and family members in wrongful death accidents, have joined forces, […]

Despite the Risks of Distracted Driving Indiana Lawmakers Lack the Resolve to Ban Handheld Cell Phones

Despite the Risks of Distracted Driving Indiana Lawmakers Lack the Resolve to Ban Handheld Cell Phones A study by the Insurance Institute for Highway Safety (IIHS), in partnership with Virginia Tech shows texting while driving (TWD) is on the rise for the age group between 16 and 24 year olds. Statistically, teens are more likely […]

Common Causes of Motorcycle Accidents

According to statistics, incidents of motorcycle accidents have been on the rise since 2006. Cycling accidents may cause serious injury or death and are often the result of one of the following circumstances: Car operator turns in front of the bike If the operator of a motorized vehicle fails to accurately judge a cyclist’s speed […]

Cell Phone Manufacturers Walk a Fine Line between Social and Personal Responsibility – Car accident lawyers

 Cell Phone Manufacturers Walk a Fine Line between Social and Personal Responsibility – Car Accident Lawyers Ward & Ward Law Firm Pressure is being put on cell phone manufacturers to include “lock-out” technology in their mobile devices to prevent drivers from accessing certain features while driving. Who bears the responsibility for car accident injuries and […]

Indiana Personal Injury Attorney Selected for Inclusion in Best Lawyers in America©

Ward & Ward Law Firm Announces Partner in Personal Injury Law Firm is Selected for Inclusion in Best Lawyers in America Indianapolis personal injury attorney, wrongful death attorney and medical malpractice attorney, Charlie Ward, has been selected by his peers for inclusion into the 23rd annual edition of The Best Lawyers in America© Indianapolis, Indiana […]